אימיוסיסט

Nchi: Israeli

Lugha: Kiebrania

Chanzo: Ministry of Health

Viambatanisho vya kazi:

BCG 81 MG/VIAL

Inapatikana kutoka:

MEDICI LTD

ATC kanuni:

L03AX03

Dawa fomu:

POWDER FOR RECONSTITUTION

Njia ya uendeshaji:

INTRA-VESICALLY

Viwandani na:

SANOFI PASTEUR LTD, CANADA

Kundi la matibabu:

BCG VACCINE

Matibabu dalili:

For the treatment of superficial transitional cell carcinoma (TCC) of the urinary bladder, regardless of antecedent intravesical treatment superficial TCC comprises the following: carcinoma in situ (CIS), papillary tumors limited to the mucosa (stage Ta), papillary tumors invoiving the lamina propria but not the muscle layer of the bladder (stage T1), or any combination thereof. Immucyst is indicated for treatment and prophylaxis of primary or recurrent carcinoma insitu (CIS) of the urinary bladder and for prophylaxis following trans-urethral resection (TUR) of primary or recurrent stage Ta and/or T1 papilary tumors.

Idhini ya tarehe:

2012-04-01